Literature DB >> 17967290

Pulmonary hypertension in older adults.

John R McArdle1, Terence K Trow, Kathryn Lerz.   

Abstract

Pulmonary hypertension is a frequently encountered problem in older patients. True idiopathic pulmonary arterial hypertension can also be seen and requires careful exclusion in older patients. Institution of therapies must be tempered with an appreciation of individual comorbidities and functional limitations that may affect patients' ability to comply and benefit from the complex treatments available for pulmonary arterial hypertension. This article reviews the existing data on the various forms of pulmonary hypertension presenting in older patients and on appropriate therapy in this challenging population.

Entities:  

Mesh:

Year:  2007        PMID: 17967290     DOI: 10.1016/j.ccm.2007.08.006

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  3 in total

1.  Pulmonary arterial hypertension in the elderly-clinical characteristics and long-term survival.

Authors:  Avi Shimony; Benjamin D Fox; Jonathan Afilalo; Lawrence G Rudski; Andrew Hirsch; David Langleben
Journal:  Lung       Date:  2012-10-11       Impact factor: 2.584

2.  Pulmonary arterial hypertension in critically ill elderly patients.

Authors:  Yun-Yun Zhang; Fan Xu; Ming Chu; Li-Qing Bi
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

3.  Clinical Characteristics of Patients Undergoing Right Heart Catheterizations in Community Hospitals.

Authors:  Samara M A Jansen; Anna E Huis In 't Veld; Peter Hans C G Tolen; Wouter Jacobs; H M Willemsen; Hans P Grotjohan; Marc Waskowsky; Jan van der Maten; Arno van der Weerdt; Romke Hoekstra; Ana J Pérez Matos; Maria J Overbeek; Sjoerd A Mollema; Lahssan H Hassan El Bouazzaoui; Joris W J Vriend; J Milena M Roorda; Ramon de Nooijer; Ivo van der Lee; A J Voogel; Johannes C Post; Thomas Macken; Jacqueline M Aerts; Marjo J T van de Ven; Heidi Bergman; Mirjam Bakker-de Boo; Roline C de Boer; Anton Vonk Noordegraaf; Frances S de Man; Harm Jan Bogaard
Journal:  J Am Heart Assoc       Date:  2022-09-05       Impact factor: 6.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.